Sanara MedTech Inc. SMTI Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sanara MedTech Inc.'s allowance for doubtful accounts receivable (current)?
- Sanara MedTech Inc. (SMTI) reported allowance for doubtful accounts receivable (current) of $1.45M in Q1 2026.
- How has Sanara MedTech Inc.'s allowance for doubtful accounts receivable (current) changed year-over-year?
- Sanara MedTech Inc.'s allowance for doubtful accounts receivable (current) increased by 38.9% year-over-year, from $1.04M to $1.45M.
- What is the long-term trend for Sanara MedTech Inc.'s allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Sanara MedTech Inc.'s allowance for doubtful accounts receivable (current) has grown at a 68.8% compound annual growth rate (CAGR), from $100.19K to $1.37M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.